Patients with autoimmune disease including SLE, T1D, or rheumatoid arthritis have defective expression and regulation of IL-2 and IL-2R resulting in dysregulated Treg function and impaired downstream signaling (41–45). This evidence concerns the gene IL2 and type 1 diabetes mellitus.